Literature DB >> 26787167

The concept of a surrogate is ill adapted to intensive care: Criteria for recognizing a reference person.

Jean-Philippe Rigaud1, Jean-Baptiste Hardy2, Nicolas Meunier-Beillard3, Hervé Devilliers4, Fiona Ecarnot5, Corinne Quesnel6, Stéphanie Gelinotte7, Pierre-Louis Declercq8, Jean-Pierre Eraldi9, François Bougerol10, Jean-Pierre Quenot11.   

Abstract

PURPOSE: In the intensive care unit (ICU), caregivers may find it difficult to identify a suitable person in the patient's entourage to serve as a reference when there is no official surrogate.
METHODS: We developed a 12-item questionnaire to identify factors potentially important for caregivers when identifying a reference person. Each criterion was evaluated as regards its importance for the role of reference. Responses were on a scale of 0 (not important) to 10 (extremely important). We recorded respondent's age, job title, and number of years' ICU experience. The questionnaire was distributed to all health care professionals in 2 French ICUs.
RESULTS: Among 144 staff, 128 were contacted; 99 completed the questionnaire (77% response rate; 20 physicians [11 residents], 51 nurses, 28 nurse's aides). Items classed as most important attributes for a reference person were knowledge of patient's wishes and values, emotional attachment, adequate understanding of the clinical history, and designation as a surrogate before admission. There were no significant differences according to respondent's age, job title, or experience.
CONCLUSION: Caregivers identify a reference person based on criteria such as knowledge of the patient's wishes, emotional bond with the patient, an adequate understanding of the clinical history, and designation as surrogate before admission.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ethics; Intensive care; Questionnaire; Surrogate

Mesh:

Year:  2015        PMID: 26787167     DOI: 10.1016/j.jcrc.2015.12.011

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  6 in total

Review 1.  What are the ethical aspects surrounding intensive care unit admission in patients with cancer?

Authors:  Jean-Philippe Rigaud; Audrey Large; Nicolas Meunier-Beillard; Stéphanie Gélinotte; Pierre-Louis Declercq; Fiona Ecarnot; Auguste Dargent; Jean-Pierre Quenot
Journal:  Ann Transl Med       Date:  2017-12

2.  Ethical challenges involved in obtaining consent for research from patients hospitalized in the intensive care unit.

Authors:  Fiona Ecarnot; Jean-Pierre Quenot; Guillaume Besch; Gaël Piton
Journal:  Ann Transl Med       Date:  2017-12

3.  Intensive care unit strain should not rush physicians into making inappropriate decisions, but merely reduce the time to the right decisions being made.

Authors:  Jean-Pierre Quenot; Fiona Ecarnot; Nicolas Meunier-Beillard; Auguste Dargent; Audrey Large; Pascal Andreu; Jean-Philippe Rigaud
Journal:  Ann Transl Med       Date:  2016-08

Review 4.  What are the ethical aspects surrounding the collegial decisional process in limiting and withdrawing treatment in intensive care?

Authors:  Jean-Pierre Quenot; Fiona Ecarnot; Nicolas Meunier-Beillard; Auguste Dargent; Audrey Large; Pascal Andreu; Jean-Philippe Rigaud
Journal:  Ann Transl Med       Date:  2017-12

5.  Psychological effects of remote-only communication among reference persons of ICU patients during COVID-19 pandemic.

Authors:  Jessy Cattelan; Sara Castellano; Hamid Merdji; Jean Audusseau; Baptiste Claude; Léa Feuillassier; Sibylle Cunat; Marc Astrié; Camille Aquin; Guillaume Buis; Edgar Gehant; Amandine Granier; Hassiba Kercha; Camille Le Guillou; Guillaume Martin; Kevin Roulot; Ferhat Meziani; Olivier Putois; Julie Helms
Journal:  J Intensive Care       Date:  2021-01-09

6.  Non-readmission decisions in the intensive care unit under French rules: A nationwide survey of practices.

Authors:  Jean-Philippe Rigaud; Mikhael Giabicani; Nicolas Meunier-Beillard; Fiona Ecarnot; Marion Beuzelin; Antoine Marchalot; Auguste Dargent; Jean-Pierre Quenot
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.